학술논문
Genome-Wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk.
Document Type
Academic Journal
Author
Wang F; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.; Moon W; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.; Letsou W; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.; Sapkota Y; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.; Wang Z; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.; Im C; School of Public Health, University of Alberta, Edmonton, Canada.; Baedke JL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.; Robison L; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.; Yasui Y; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.; School of Public Health, University of Alberta, Edmonton, Canada.
Source
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Subject
Language
English
Abstract
Numerous common genetic variants have been linked to breast cancer risk, but they only partially explain the total breast cancer heritability. Inference from Nordic population-based twin data indicates rare high-risk loci as the chief determinant of breast cancer risk. Here, we use haplotypes, rather than single variants, to identify rare high-risk loci for breast cancer. With computationally phased genotypes from 181,034 white British women in the UK Biobank, a genome-wide haplotype-breast cancer association analysis was conducted using sliding windows of 5 to 500 consecutive array-genotyped variants. In the discovery stage, haplotype-breast cancer associations were evaluated retrospectively in the prestudy-enrollment data including 5,487 breast cancer cases. Breast cancer hazard ratios (HR) for additive haplotypic effects were estimated using Cox regression. The replication analysis included a prospective cohort of women free of breast cancer at enrollment, of whom 3,524 later developed breast cancer. This two-stage analysis detected 13 rare loci (frequency <1%), each associated with an appreciable breast cancer-risk increase (discovery: HRs = 2.84-6.10, P < 5 × 10-8; replication: HRs = 2.08-5.61, P < 0.01). In contrast, the variants that formed these rare haplotypes individually exhibited much smaller effects. Functional annotation revealed extensive cis-regulatory DNA elements in breast cancer-related cells underlying the replicated rare haplotypes. Using phased, imputed genotypes from 30,064 cases and 25,282 controls in the DRIVE OncoArray case-control study, 6 of the 13 rare-loci associations were found generalizable (odds ratio estimates: 1.48-7.67, P < 0.05). This study demonstrates the complementary advantage of utilizing rare haplotypes to capture novel risk loci and suggests the potential for the discovery of more genetic elements contributing to cancer heritability as large data sets of germline whole-genome sequencing become available.
Significance: A genome-wide two-stage haplotype analysis identifies rare haplotypes associated with breast cancer risk and suggests that the rare risk haplotypes represent long-range interactions with regulatory consequences influencing cancer risk.
(©2022 American Association for Cancer Research.)
Significance: A genome-wide two-stage haplotype analysis identifies rare haplotypes associated with breast cancer risk and suggests that the rare risk haplotypes represent long-range interactions with regulatory consequences influencing cancer risk.
(©2022 American Association for Cancer Research.)